Appointment of Non Executive Director

Agenix is pleased to announce the appointment of Mr Craig Chapman as a non-executive Director with immediate effect.

Craig has over 25 years experience across a range of service sectors and has been instrumental in a number of highly successful consolidation plays listed on the ASX including S8 (SEL), Greencross (GXL) and G8 Education (GEM).

Craig has held senior management roles, company secretarial positions and directorships with the above companies.

Craig holds a Bachelor of Commerce degree from the University of Queensland and is a CPA. He also holds a Graduate Diploma in Applied Corporate Governance and is a member of the Institute of Chartered Secretaries and Administrators.

In announcing the appointment, Agenix Executive Chairman, Nick Weston said “Craig’s experience in financial markets, management and his professional background will further strengthen our board’s focus on the bottom line and complement our existing expertise”.

Agenix is commercialising a revolutionary blood clot diagnostic called ThromboView, a human health point of care diagnostic platform called DiagnostIQ and a hepatitis B therapy for China.

For more information please contact:

Nicholas Weston
Agenix Limited
Tel: 1300 132 551